This excerpt taken from the ARRS 10-K filed Mar 1, 2007.
Below are the key line items affecting investing activities (in millions):
Capital Expenditures Capital expenditures are mainly for test equipment, laboratory equipment, and computing equipment. We anticipate investing approximately $12.0 million in 2007.
Acquisitions/Other This represents cash investments we have made in our various acquisitions.
Purchases and Disposals of Short-Term Investments This represents purchases and disposals of auction rate securities held as short-term investments.
Proceeds from Sale of Investments This represents the cash proceeds we received from the liquidation of excess assets from our deferred compensation plan.